Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000077

CEO bought 8,990 shares at $0.15 ($1,357)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-06 Purchase : show line 1 in the form +3,990 $0.15 $602 4,961,844 I
2016-01-07 Purchase : show line 2 in the form +5,000 $0.15 $755 4,966,844 I
Open-market purchases · 8,990 sh · avg $0.15 · $1,357
Loading xslF345X03/primary_doc.xml…